Bevicra 400mg Injection: Effective Treatment for Your Needs

Bevicra 400mg Injection

Description:

• Bevicra 400mg Injection is an anticancer medicine containing the active ingredient Bevacizumab.
• It is used to prevent the growth of tumors and is indicated in combination with other chemotherapy drugs to treat various types of cancer.

Uses:

• Glioblastoma multiforme (brain cancer).
• Persistent, recurrent, or metastatic breast cancer.
• Metastatic cervical cancer.
• Advanced kidney cancer.
• Metastatic colorectal cancer.
• Advanced non-small-cell lung cancer.
• Liver cancer (Hepatocellular carcinoma).
• Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer.

Therapeutic Effects:

• Bevicra 400mg Injection is a recombinant humanized monoclonal antibody that targets the protein vascular endothelial growth factor A (VEGF-A).
• It inhibits the formation of blood vessels that supply oxygen and nutrients to the tumor, thereby slowing down cancer progression.

Administration:

• The injection is administered intravenously by a physician or nurse.
• The infusion should be given immediately after dilution.

Safety Advice:

• Pregnancy: Inform your physician before starting treatment if you are pregnant or planning pregnancy.
• Breastfeeding: Avoid breastfeeding for at least 6 months after treatment.
• Lungs and Liver: Inform your doctor if you have any lung or liver conditions.
• Alcohol: Consult your doctor about alcohol consumption during treatment.
• Driving: Avoid driving or operating machinery due to potential dizziness or sleepiness.

Interaction with Other Drugs:

• Inform your doctor about all medications, supplements, and herbal products you are taking.
• Certain medications may interact with Bevicra 400mg Injection and cause undesirable side effects.

Storage:

• Store Bevicra 400mg Injection at 2˚C to 8˚C.
• Do not freeze or shake.
• Protect from light.
• Keep out of reach of children.

Side Effects:

• Serious: Headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing, protein in urine, severe infections, blood clots, gut perforation, nosebleeds, heart problems, mouth sores.
• Common: Numbness in hands or feet, weakness, diarrhea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, fever, dry skin, back pain.

FAQs:

1. Is Bevicra 400mg Injection used as standalone treatment in cancers?

   • Bevicra 400mg Injection can be used as monotherapy or in combination with chemotherapy or immunotherapy medications.

2. Is it safe for women to use Bevicra 400mg Injection?

   • Women with reproductive potential should discuss effective birth control methods with their doctor during treatment and for at least 6 months after completion.

3. Is it safe to undergo surgery during the treatment with Bevicra 400mg Injection?

   • Avoid surgery within 28 days before or after treatment due to the risk of bleeding and poor wound healing.

4. Do the side effects of Bevicra 400mg Injection last for a chronic period?

   • Side effects occur until the drug concentration stays in the body, which is approximately 4 months after the final dose.

5. How is Bevicra 400mg Injection administered?

   • The injection is given intravenously, and the amount is based on the patient’s body weight, height, and age. The first dose is administered for 90 minutes, and if well tolerated, the infusion time can be reduced to 30 minutes.

6. Can I take Bevicra 400mg Injection if I am pregnant?

   • Inform your physician before starting treatment if you are pregnant or planning pregnancy, as the medicine may harm the unborn baby.

Fact Box:

• Molecule name: Bevacizumab.
• Therapeutic class: Anticancer.
• Pharmacological class: VEGF Inhibitor.

Теги: Bevicra400mg, Injection, Pharmaceuticals, Medicine, CancerTreatment